Premium
Multiparametric magnetic resonance imaging: Current role in prostate cancer management
Author(s) -
Ueno Yoshiko,
Tamada Tsutomu,
Bist Vipul,
Reinhold Caroline,
Miyake Hideaki,
Tanaka Utaru,
Kitajima Kazuhiro,
Sugimura Kazuro,
Takahashi Satoru
Publication year - 2016
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/iju.13119
Subject(s) - medicine , magnetic resonance imaging , prostate cancer , prostate , radiology , ultrasound , magnetic resonance spectroscopic imaging , cancer
Digital rectal examination, serum prostate‐specific antigen screening and transrectal ultrasound‐guided biopsy are conventionally used as screening, diagnostic and surveillance tools for prostate cancer. However, they have limited sensitivity and specificity. In recent years, the role of multiparametric magnetic resonance imaging has steadily grown, and is now part of the standard clinical management in many institutions. In multiparametric magnetic resonance imaging, the morphological assessment of T2‐weighted imaging is correlated with diffusion‐weighted imaging, dynamic contrast‐enhanced imaging perfusion and/or magnetic resonance spectroscopic imaging. Multiparametric magnetic resonance imaging is currently regarded as the most sensitive and specific imaging technique for the evaluation of prostate cancer, including detection, staging, localization and aggressiveness evaluation. This article presents an overview of multiparametric magnetic resonance imaging, and discusses the current role of multiparametric magnetic resonance imaging in the different fields of prostate cancer management.